"U.S. pharmaceutical gray markets : why do they persist-and what do about them?"
Year of publication: |
2016
|
---|---|
Authors: | Hemphill, Thomas A. |
Published in: |
Business and society review : a quarterly forum on the role of business in a free society. - Malden, Mass. [u.a.] : Blackwell, ISSN 0045-3609, ZDB-ID 608367-5. - Vol. 121.2016, 4, p. 529-547
|
Subject: | Grauer Markt | Grey market | Gesundheitswesen | Health care system | Regulierung | Regulation | Drogenpolitik | Drug policy | Pharmaindustrie | Pharmaceutical industry | USA | United States | 2005-2014 |
-
Pharmaceutical Cost-Sharing Systems and Savings for Health Care Systems from Parallel Trade
Birg, Laura, (2013)
-
The business of health : the role of competition, markets, and regulation
Ohsfeldt, Robert L., (2006)
-
American health care : government, market processes, and the public interest
Feldman, Roger D., (2000)
- More ...
-
Hemphill, Thomas A., (2020)
-
Generic drug competition: The pharmaceutical industry “gaming” controversy
Hemphill, Thomas A., (2019)
-
White III, George O., (2020)
- More ...